CCR8 and glioblastoma: In GBM, the LDHA inhibitor oxamate can enhance the efficacy of CAR-T cell therapy by inhibiting the lactylation of exonucleases and C-C motif chemokine receptor 8 (CCR8) (Sun T. et al., 2023).